Ledger.Open graph →

SEC Form D · filed January 9, 2024

Akari Therapeutics Plc

Offering

$2.0M

Sold

$2.0M

Exemption

Rule 506(b)

Industry

Other Health Care

Location

BOSTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Dr. Ray Prudo · Boston, MADirector Rachelle Jacques · Boston, MAExec · Director Donald Williams · Boston, MADirector Wendy Dicicco · Boston, MAExec Wa'El Hashad · Boston, MADirector Michael Grissinger · Boston, MADirector Wa'El Hashad · Boston, MADirector Donald Williams · Boston, MADirector Michael Grissinger · Boston, MADirector Dr. Ray Prudo · Boston, MADirector Rachelle Jacques · Boston, MAExec · Director Wendy Dicicco · Boston, MAExec Samir Patel · Irmo, SCDirector Brian Derrick · NEW YORK, NYDirector Taylor Ourada · NEW YORK, NYExec Colin T. Mackay · Grand Cayman, Cayman IslandsDirector Maxwell Deibel · Boca Raton, FLExec · Director Justin Cooper · Boca Raton, FLDirector Chad M. Hagler · RALEIGH, NCDirector Samir Patel · Goodlettsville, TNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗